Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

PeptiGrowth – PG-011

The FGF2 alternative peptide (PG-011) is a dimeric peptide composed of cyclic peptides that bind to human FGFR1c.

PG-011 exhibits agonist activity toward FGFR1c by binding to it, thereby activating signaling pathways in various types of cells (Fig.1).

FGF2 is a well-known growth factor that plays a crucial role in promoting the proliferation and differentiation of various cell types, including induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs). However, conventional FGF2 is highly unstable, often requiring high concentrations and frequent media changes, which significantly increases costs and operational burdens.


Key comparative advantages of PG-011:

  • Effective activation of FGFR1c and proliferation activity in human MSCs and bovine muscle satellite cells
  • Ability to maintain the undifferentiated state of human iPSCs
  • Superior stability compared to FGF2

Learn more about PG-011

Download the flyer >

View the PeptiGrowth product lineup

Download the brochure >

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

Request a Quote

Request Quote

Recent Posts

Roche – New KAPA NGS Reagents

Roche KAPA kits offer a range of high-performance products for molecular biology applications in next-generation sequencing (NGS). KAPA RNA EvoPrep Kit The KAPA RNA EvoPrep…

Read full article

2027 Abacus dx Emerging Investigators Grant

COMING SOON Grant in Research Funding Empowering the Next Generation of Scientific Leaders Stay tuned for the 2027 Abacus dx Emerging Investigators Grant. More information…

Read full article

Developing Diagnostic Kits for Ovarian Cancer

In Australia, ovarian cancer is the deadliest reproductive cancer. The average five‑year survival rate sits at around 49%, compared with about 92% for breast cancer,…

Read full article